• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Session 1: Discussant

Article

In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective.

In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective. "There is no one-size-fits-all measure of diabetes quality or glycemic care," said Dr Herman. Dr Herman also discussed his viewpoint as a clinical endocrinologist diabetologist. "So patients who are remarkably likely to have targets I think the targets were appropriately modified based on risk of hypoglycemia," said Herman. "I do have general concern that maybe the targets are even too low based on the evidence."

Related Videos
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Stephen Nicholls, MD, Monash University and Victorian Heart Hospital
Amal Agarwal, DO, MBA
Dr Robert Groves
Dr Robert Groves
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.